Elizabeth A. Yamashita - Net Worth and Insider Trading
Elizabeth A. Yamashita Net Worth
The estimated net worth of Elizabeth A. Yamashita is at least $2,553 dollars as of 2024-11-10. Elizabeth A. Yamashita is the VP, Regulatory Affairs of Outlook Therapeutics Inc and owns about 404 shares of Outlook Therapeutics Inc (OTLK) stock worth over $2,553. Details can be seen in Elizabeth A. Yamashita's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elizabeth A. Yamashita has not made any transactions after 2017-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elizabeth A. Yamashita
Elizabeth A. Yamashita Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elizabeth A. Yamashita owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Elizabeth A. Yamashita’s form 4 insider trades.
Insider Ownership Summary of Elizabeth A. Yamashita
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
OTLK | Outlook Therapeutics Inc | 2017-12-22 | VP & Regulatory Affairs |
Elizabeth A. Yamashita Latest Holdings Summary
Elizabeth A. Yamashita currently owns a total of 1 stock. Elizabeth A. Yamashita owns 404 shares of Outlook Therapeutics Inc (OTLK) as of December 22, 2017, with a value of $2,553.
Latest Holdings of Elizabeth A. Yamashita
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
OTLK | Outlook Therapeutics Inc | 2017-12-22 | 404 | 6.32 | 2,553 |
Holding Weightings of Elizabeth A. Yamashita
Elizabeth A. Yamashita Form 4 Trading Tracker
According to the SEC Form 4 filings, Elizabeth A. Yamashita has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 101 shares on December 22, 2017, which brought Elizabeth A. Yamashita around $18,272.
Insider Trading History of Elizabeth A. Yamashita
- 1
Elizabeth A. Yamashita Trading Performance
Elizabeth A. Yamashita Ownership Network
Ownership Network List of Elizabeth A. Yamashita
Ownership Network Relation of Elizabeth A. Yamashita
Elizabeth A. Yamashita Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Elizabeth A. Yamashita is the VP & Regulatory Affairs of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Elizabeth A. Yamashita made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Elizabeth A. Yamashita Mailing Address
Above is the net worth, insider trading, and ownership report for Elizabeth A. Yamashita. You might contact Elizabeth A. Yamashita via mailing address: C/o Oncobiologics, Inc., 7 Clarke Drive, Cranbury Nj 08512.